Last updated: 4 June 2019 at 3:39pm EST

Arthur Levine Net Worth




The estimated Net Worth of Arthur Levine is at least $1.22 Milhão dollars as of 10 September 2018. Arthur Levine owns over 166 units of Sensus Healthcare Inc stock worth over $1,183,862 and over the last 8 years Arthur sold SRTS stock worth over $31,144.

Arthur Levine SRTS stock SEC Form 4 insiders trading

Arthur has made over 13 trades of the Sensus Healthcare Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Arthur sold 166 units of SRTS stock worth $1,252 on 10 September 2018.

The largest trade Arthur's ever made was selling 1,228 units of Sensus Healthcare Inc stock on 18 June 2018 worth over $9,247. On average, Arthur trades about 224 units every 19 days since 2016. As of 10 September 2018 Arthur still owns at least 201,337 units of Sensus Healthcare Inc stock.

You can see the complete history of Arthur Levine stock trades at the bottom of the page.



What's Arthur Levine's mailing address?

Arthur's mailing address filed with the SEC is 851 BROKEN SOUND PARKWAY NW STE 215, , BOCA RATON, FL, 33487.

Insiders trading at Sensus Healthcare Inc

Over the last 8 years, insiders at Sensus Healthcare Inc have traded over $8,288,024 worth of Sensus Healthcare Inc stock and bought 88,000 units worth $292,820 . The most active insiders traders include Joseph C Sardano, Stephen Brad Cohen, eAnthony Benedict Petrelli. On average, Sensus Healthcare Inc executives and independent directors trade stock every 29 days with the average trade being worth of $58,482. The most recent stock trade was executed by John Heinrich on 17 May 2024, trading 20,000 units of SRTS stock currently worth $123,400.



What does Sensus Healthcare Inc do?

sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.



Complete history of Arthur Levine stock trades at Sensus Healthcare Inc

Acionista maioritário
Trans.
Transação
Preço total
Arthur Levine
Diretor Financeiro
Venda $1,252
10 Sep 2018
Arthur Levine
Diretor Financeiro
Venda $645
28 Aug 2018
Arthur Levine
Diretor Financeiro
Venda $2,648
8 Aug 2018
Arthur Levine
Diretor Financeiro
Venda $150
2 Aug 2018
Arthur Levine
Diretor Financeiro
Venda $330
26 Jun 2018
Arthur Levine
Diretor Financeiro
Venda $6,685
21 Jun 2018
Arthur Levine
Diretor Financeiro
Venda $9,247
18 Jun 2018
Arthur Levine
Diretor Financeiro
Venda $1,302
27 Oct 2017
Arthur Levine
Diretor Financeiro
Venda $660
13 Sep 2017
Arthur Levine
Diretor Financeiro
Venda $2,286
7 Sep 2017
Arthur Levine
Diretor Financeiro
Venda $2,502
5 Sep 2017
Arthur Levine
Diretor Financeiro
Venda $1,812
25 Aug 2017
Arthur Levine
Diretor Financeiro
Venda $1,626
24 Aug 2017


Sensus Healthcare Inc executives and stock owners

Sensus Healthcare Inc executives and other stock owners filed with the SEC include: